{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-011771","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2023-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.687307+00:00","generated_at":"2026-06-17T04:09:34.883103+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Evofem raises ~$490k net via convertible notes at 8%; CEO Pelletier appointed Secretary","bullets":["Issued $538,462 principal in senior subordinated convertible notes, 8% interest (12% on default), convertible at $0.01/share.","Warrants to purchase up to 76.9M shares at $0.01/share, five-year term, with price adjustment provisions.","Net proceeds ~$490,000; notes mature March 6, 2026; investors paid ~$650 per $1,000 principal.","CEO Saundra Pelletier appointed as Secretary, replacing Justin J. File who resigned.","Offering closed on April 5, 2023; notes include change-of-control redemption at 125% premium and various covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-011771","json":"https://secwatch.observer/filing/0001493152-23-011771.json","markdown":"https://secwatch.observer/filing/0001493152-23-011771.md","text":"https://secwatch.observer/filing/0001493152-23-011771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223011771/0001493152-23-011771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223011771/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T04:09:34.883103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c2f8ea61ed","claim":"Justin J. File resigned as Secretary at Evofem Biosciences, Inc..","evidence_excerpt":"which was left vacant as a result of the resignation by Justin J. File.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223011771/0001493152-23-011771-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Secretary"}],"fact_type":"executive_change"},{"claim_id":"e4a45974c4","claim":"Saundra Pelletier was appointed as Secretary at Evofem Biosciences, Inc..","evidence_excerpt":"On April 5, 2023, the Company’s board of directors appointed Saundra Pelletier to fill the role as the Secretary of the Company, which was left vacant as a result of the resignation by Justin J. File.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223011771/0001493152-23-011771-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Secretary"}],"fact_type":"executive_change"},{"claim_id":"db01a49d09922c60e4979941530d9bee79a80014","claim":"Evofem Biosciences, Inc. entered into Securities Purchase Agreement with Investors valued at Senior subordinate convertible notes due in aggregate original principal amount of $769,230.76, inte (effective 2023-04-05).","evidence_excerpt":"On April 5, 2023, Evofem Biosciences, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (“ SPA ”), with certain investors (the “ Investors ”) providing for the sale and issuance of senior subordinate convertible notes due in the aggregate original principal amount of $769,230.76 (the “ Notes ”) and warrants (“ Warrants ”) to purchase an aggregate 26,923,077 shares of common stock, par value $0.0001 per share (the “ Common Stock ”) (collectively, the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315223011771/0001493152-23-011771-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Investors"},{"label":"Value","value":"Senior subordinate convertible notes due in aggregate original principal amount of $769,230.76, inte"},{"label":"Effective","value":"2023-04-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}